SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-002334
Filing Date
2022-02-28
Accepted
2022-02-28 15:24:14
Documents
67
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fencf-20211231x10k.htm   iXBRL 10-K 2350734
2 EX-23.1 fencf-20211231xex23d1.htm EX-23.1 4878
3 EX-31.1 fencf-20211231xex31d1.htm EX-31.1 15070
4 EX-31.2 fencf-20211231xex31d2.htm EX-31.2 15144
5 EX-32.1 fencf-20211231xex32d1.htm EX-32.1 8447
6 EX-99.1 fencf-20211231xex99d1.htm EX-99.1 148569
7 GRAPHIC fencf-20211231x10k005.jpg GRAPHIC 10873
8 GRAPHIC fencf-20211231xex99d1001.jpg GRAPHIC 1766
  Complete submission text file 0001558370-22-002334.txt   7606482

Data Files

Seq Description Document Type Size
9 EX-101.SCH fencf-20211231.xsd EX-101.SCH 52073
10 EX-101.CAL fencf-20211231_cal.xml EX-101.CAL 38019
11 EX-101.DEF fencf-20211231_def.xml EX-101.DEF 206401
12 EX-101.LAB fencf-20211231_lab.xml EX-101.LAB 338932
13 EX-101.PRE fencf-20211231_pre.xml EX-101.PRE 316476
61 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20211231x10k_htm.xml XML 1156530
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 22688710
SIC: 2836 Biological Products, (No Diagnostic Substances)